Estimate Recalculated Sep 17, 2025 09:46PM EST
Paul B Manning has an estimated net worth of $337 Million. This is based on reported shares across multiple companies, which include Liquidia Corp, Verrica Pharmaceuticals Inc., Taysha Gene Therapies, Inc., Acumen Pharmaceuticals, Inc., AveXis, Inc., Candel Therapeutics, Inc., Dova Pharmaceuticals, Inc., Pasithea Therapeutics Corp., and PERRIGO CO.
Paul B Manning's CIK is 0001494695
2018 was Paul B Manning's most active year for acquiring shares with 20 total transactions. Paul B Manning's most active month to acquire stocks was the month of May. 2018 was Paul B Manning's most active year for disposing of shares, totalling 5 transactions. Paul B Manning's most active month to dispose stocks was the month of April. 2021 saw Paul B Manning paying a total of $14,410,287.67 for 1,822,087 shares, this is the most they've acquired in one year. In 2019 Paul B Manning cashed out on 12,979,016 shares for a total of $356,922,940.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!